Tau-binding protein PRMT8 facilitates vacuole degeneration in the brain.
Autorzy:
Ishii A; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan.; Laboratory of Comparative Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonancho, Musashino City, Tokyo 180-8602, Japan. Matsuba Y; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan. Mihira N; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan. Kamano N; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan. Saito T; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan.; Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.; Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan. MuramatsuSI; Division of Neurological Gene Therapy, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi 329-0498, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. Yokosuka M; Laboratory of Comparative Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonancho, Musashino City, Tokyo 180-8602, Japan. Saido TC; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan. Hashimoto S; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan.
Conformational change of RNA-helicase DHX30 by ALS/FTD-linked FUS induces mitochondrial dysfunction and cytosolic aggregates.
Autorzy:
Hikiami R; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.; Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan. Morimura T; Research Center for Animal Life Science, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan. Ayaki T; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan. Tsukiyama T; Research Center for Animal Life Science, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, 606-8501, Japan. Morimura N; Department of Integrative Physiology, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan. Kusui M; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. Wada H; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. Minamiyama S; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.; Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan. Shodai A; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. Asada-Utsugi M; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. MuramatsuSI; Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Tochigi, 320-0498, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-0071, Japan. Ueki T; Department of Integrative Anatomy, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan. Takahashi R; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan. Urushitani M; Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. .; Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Sep 26; Vol. 12 (1), pp. 16030. Date of Electronic Publication: 2022 Sep 26.
Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies.
Autorzy:
Ito M; Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Tochigi, Japan. Takino N; Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Tochigi, Japan. Nomura T; KAINOS Laboratories, Inc., Tokyo, Japan. Kan A; KAINOS Laboratories, Inc., Tokyo, Japan. MuramatsuSI; Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Tochigi, Japan. .; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 29; Vol. 11 (1), pp. 9322. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji:
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Autorzy:
Haddar M; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Uno K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Azuma K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Nitta A; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Pokaż więcej
Źródło:
Addiction biology [Addict Biol] 2020 May; Vol. 25 (3), pp. e12749. Date of Electronic Publication: 2019 Apr 05.
Pcdhβ deficiency affects hippocampal CA1 ensemble activity and contextual fear discrimination.
Autorzy:
Asai H; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Ohkawa N; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan.; Precursory Research for Embryonic Science and Technology (PRESTO), JST, Saitama, 332-0012, Japan. Saitoh Y; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan.; Precursory Research for Embryonic Science and Technology (PRESTO), JST, Saitama, 332-0012, Japan. Ghandour K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Murayama E; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Nishizono H; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama, 930-0194, Japan. Matsuo M; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama, 930-0194, Japan. Hirayama T; Department of Anatomy and Developmental Neurobiology, Tokushima University, Tokushima, 770-8501, Japan. Kaneko R; Bioresource Center, Gunma University Graduate School of Medicine, Gunma, 371-8511, Japan. MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Tochigi, 329-0498, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan. Yagi T; KOKORO-Biology Group, Laboratories for Integrated Biology, Graduate School of Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan. Inokuchi K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. .; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. .
Pokaż więcej
Źródło:
Molecular brain [Mol Brain] 2020 Jan 20; Vol. 13 (1), pp. 7. Date of Electronic Publication: 2020 Jan 20.
Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex.
Autorzy:
Haddar M; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Uno K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.; Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan. Hamatani K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. MuramatsuSI; Division of Neurological Gene Therapy, Open Inovation Center, Jichi Medical University, Shimotsuke, Japan.; Center for Gene & Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Nitta A; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2019 Sep; Vol. 39 (3), pp. 209-216. Date of Electronic Publication: 2019 Jul 08.
Face-to-trait inferences in patients with Parkinson's disease.
Autorzy:
Hirai M; a Center for Development of Advanced Medical Technology , Jichi Medical University , Tochigi , Japan.; b Centre for Brain & Cognitive Development, Birkbeck , University of London , London , UK. Sakurada T; a Center for Development of Advanced Medical Technology , Jichi Medical University , Tochigi , Japan.; c Department of Neurosurgery , Jichi Medical University , Tochigi , Japan. MuramatsuSI; d Division of Neurology , Jichi Medical University , Tochigi , Japan.; e Center for Gene & Cell Therapy, The Institute of Medical Science , The University of Tokyo , Tokyo , Japan.
Artificial association of memory events by optogenetic stimulation of hippocampal CA3 cell ensembles.
Autorzy:
Oishi N; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Nomoto M; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Ohkawa N; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan.; Precursory Research for Embryonic Science and Technology (PRESTO), JST, University of Toyama, Toyama, 930-0194, Japan. Saitoh Y; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Sano Y; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan.; Present address: Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, 278-8510, Japan. Tsujimura S; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. Nishizono H; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan.; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama, 930-0194, Japan. Matsuo M; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama, 930-0194, Japan. MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Tochigi, 329-0498, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan. Inokuchi K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. .; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), University of Toyama, Toyama, 930-0194, Japan. .
Pokaż więcej
Źródło:
Molecular brain [Mol Brain] 2019 Jan 08; Vol. 12 (1), pp. 2. Date of Electronic Publication: 2019 Jan 08.
Synapse-specific representation of the identity of overlapping memory engrams.
Autorzy:
Abdou K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.; Japan Science and Technology Agency, CREST, University of Toyama, Toyama 930-0194, Japan. Shehata M; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.; Japan Science and Technology Agency, CREST, University of Toyama, Toyama 930-0194, Japan. Choko K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.; Japan Science and Technology Agency, CREST, University of Toyama, Toyama 930-0194, Japan. Nishizono H; Japan Science and Technology Agency, CREST, University of Toyama, Toyama 930-0194, Japan.; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama 930-0194, Japan. Matsuo M; Division of Animal Experimental Laboratory, Life Science Research Center, University of Toyama, Toyama 930-0194, Japan. MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Tochigi 3290498, Japan.; Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan. Inokuchi K; Department of Biochemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan. .; Japan Science and Technology Agency, CREST, University of Toyama, Toyama 930-0194, Japan.
Shati/Nat8l and N -acetylaspartate (NAA) Have Important Roles in Regulating Nicotinic Acetylcholine Receptors in Neuronal and Psychiatric Diseases in Animal Models and Humans
Autorzy:
Nitta A; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Noike H; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Sumi K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Miyanishi H; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Tanaka T; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Takaoka K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Nagakura M; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Iegaki N; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Kaji J; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Miyamoto Y; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Tochigi, Japan; Center for Gene & Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan Uno K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit.
Autorzy:
Fu K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan. Miyamoto Y; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan. Sumi K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan. Saika E; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan. MuramatsuSI; Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.; Center for Gene & Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Uno K; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan. Nitta A; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Dec 06; Vol. 12 (12), pp. e0189006. Date of Electronic Publication: 2017 Dec 06 (Print Publication: 2017).
In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells.
Autorzy:
Ito H; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Shiwaku H; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Yoshida C; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Homma H; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Luo H; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Chen X; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Fujita K; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan. Musante L; Department of Human Molecular Genetics, Max-Planck Institute for Molecular Genetics, Berlin-Dahlem, Germany. Fischer U; Department of Human Molecular Genetics, Max-Planck Institute for Molecular Genetics, Berlin-Dahlem, Germany. Frints SG; 1] Department of Clinical Genetics, University Hospital azM Maastricht, Maastricht, The Netherlands [2] School for Oncology and Developmental Biology, GROW, Maastricht University, Maastricht, The Netherlands. Romano C; Unità Operativa Complessa di Pediatria e Genetica Medica, IRCCS Associazione Oasi Maria Santissima, Troina (Enna), Italy. Ikeuchi Y; 1] Department of Anatomy and Neurobiology, Washington University School of Medicine, St Louis, MO, USA [2] Department of Neurobiology, Harvard Medical School, Boston, MA, USA. Shimamura T; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Imoto S; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Miyano S; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. MuramatsuSI; Department of Neurology, Jichi Medical University, Tochigi, Japan. Kawauchi T; Department of Anatomy, Keio University School of Medicine, Tokyo, Japan. Hoshino M; Department of Biochemistry and Cellular Biology, National Center for Neurology and Psychiatry, Tokyo, Japan. Sudol M; Laboratory of Signal Transduction and Proteomic Profiling, Weis Center for Research, Geisinger Clinic, Danville, PA, USA. Arumughan A; Department of Neurogenetics, Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany. Wanker EE; Department of Neurogenetics, Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany. Rich T; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Schwartz C; JC Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, SC, USA. Matsuzaki F; Laboratory for Cell Asymmetry, Center for Developmental Biology, RIKEN, Chuo-ku, Kobe, Japan. Bonni A; 1] Department of Anatomy and Neurobiology, Washington University School of Medicine, St Louis, MO, USA [2] Department of Neurobiology, Harvard Medical School, Boston, MA, USA. Kalscheuer VM; Department of Human Molecular Genetics, Max-Planck Institute for Molecular Genetics, Berlin-Dahlem, Germany. Okazawa H; Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło:
Molecular psychiatry [Mol Psychiatry] 2015 Apr; Vol. 20 (4), pp. 459-71. Date of Electronic Publication: 2014 Jul 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
